Environmental Health Effects on Your Physiology
- Conditions
- Obesity
- Registration Number
- NCT03986814
- Lead Sponsor
- University of Colorado, Boulder
- Brief Summary
This study evaluates the associations between exposure to air pollutants, green space, and the gut microbiome and metabolome.
- Detailed Description
A rapidly evolving field of study suggests a link between the gut microbiome and fecal metabolome with obesity. Recent studies show that environmental exposures, such as ambient air pollution (AAP) exposure can affect gut bacteria and modify risk for obesity. Additionally, proximity to green space has been shown to reduce exposure to air pollutants and increase gut microbial diversity. The investigator's preliminary work has shown that near-roadway air pollution exposure was positively correlated with gut microbial taxa that have been linked with obesity. These findings suggest that air pollution exposure may increase susceptibility to obesity through alterations in the composition and function of the gut microbiome. Despite this, no studies have systematically examined the impact of air pollutants and green space on the gut microbiome and metabolome among adolescents. The overall goal of this research is to determine whether exposure to air pollutants and/or green space affect the gut microbiome and metabolome in young adults residing in Denver, Colorado. This study will examine residential-based estimates of air pollution exposure and green space and also perform detailed gut microbial and metabolite profiling in 100 adolescent and young adults.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 92
- The participant population includes young adults (18-25 years of age) who live in Denver, Colorado.
- Exclusion criteria include physical, mental, or cognitive disability that prevents participation
- Current incarceration
- Antibiotic usage in the previous month
- Pregnant or nursing
- Non-English speaking
- Any medical conditions known to affect body composition, insulin secretion, or the gut microbiota (i.e., type 1 or 2 diabetes, intestinal bowel disease, Crohn's Disease, kidney disease, heart disease, autoimmune disease).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body mass index (BMI) Measured once at baseline visit date Weight and height will be combined to report BMI in kg/m\^2
Gut Microbiome Measured once at baseline visit date 16S rRNA and Shotgun Sequencing
Fecal Metabolome Measured once at baseline visit date Targeted and/or Un-targeted Metabolomics
Body Composition Measured once at baseline visit date Waist and hip measurements will be taken
- Secondary Outcome Measures
Name Time Method Physical Activity Measured once at baseline International Physical Activity Questionnaire
Fasting Insulin Measured once at baseline Fasting insulin (uU/mL)
Air Pollution One year before baseline visit date Modeled residential exposure to air pollution
Green Space One year before baseline visit date Modeled residential exposure to green space
Serum Metabolome Measured once at baseline visit date Targeted and/or Un-targeted Metabolomics
Diet Measured once at baseline Automated Self-Administered 24-Hour (ASA24)
Fasting Glucose Measured once at baseline Fasting Glucose (mg/dl)
Trial Locations
- Locations (1)
Clinical and Translational Research Center
🇺🇸Boulder, Colorado, United States